George Sopko Selected Research

oxidized low density lipoprotein

4/2011	Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation study.
4/2005	Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.
5/2004	Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics.
7/2003	Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George Sopko Research Topics

Disease

35	Heart Failure 03/2022 - 02/2004
35	Ischemia 01/2021 - 06/2002
31	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 05/2002
13	Myocardial Infarction 01/2019 - 11/2002
12	Out-of-Hospital Cardiac Arrest 01/2021 - 04/2010
12	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 12/2002
10	Chest Pain (Chest Pains) 04/2020 - 06/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 05/2019 - 06/2002
8	Hypertension (High Blood Pressure) 01/2019 - 02/2004
7	Stroke (Strokes) 01/2022 - 02/2004
7	Atherosclerosis 05/2019 - 02/2004
7	Coronary Disease (Coronary Heart Disease) 10/2018 - 04/2005
6	Heart Arrest (Cardiac Arrest) 01/2020 - 09/2011
5	Shock 01/2020 - 04/2010
5	Pathologic Constriction (Stenosis) 08/2018 - 07/2003
4	Cardiomyopathies (Cardiomyopathy) 01/2019 - 12/2007
4	Left Ventricular Dysfunction 04/2016 - 12/2007
4	Infarction (Infarctions) 03/2012 - 12/2006
3	Coronary Stenosis (Coronary Artery Stenosis) 04/2011 - 06/2002
3	Inflammation (Inflammations) 11/2005 - 02/2004
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 10/2010
2	Hyperlipidemias (Hyperlipidemia) 01/2019 - 07/2003
2	Menstruation Disturbances 01/2016 - 04/2008
2	Renal Insufficiency (Renal Failure) 08/2015 - 06/2002
2	Wounds and Injuries (Trauma) 12/2013 - 10/2010
2	Obesity 09/2013 - 09/2004
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2008 - 02/2004
2	Dyslipidemias (Dyslipidemia) 05/2004 - 02/2004
1	Overweight 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2021
1	Ventricular Fibrillation 01/2020
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020
1	Ventricular Tachycardia 01/2020
1	Chronic Limb-Threatening Ischemia 01/2016
1	Respiratory Sounds (Crackle) 03/2012

Drug/Important Bio-Agent (IBA)

9	omega-Chloroacetophenone (Mace)IBA 01/2022 - 07/2008
8	Hormones (Hormone)IBA 09/2011 - 12/2002
6	C-Reactive ProteinIBA 01/2017 - 02/2004
6	CholesterolIBA 09/2013 - 12/2002
6	Adenosine (Adenocard)FDA LinkGeneric 06/2010 - 04/2003
4	Biomarkers (Surrogate Marker)IBA 05/2019 - 05/2009
4	Phenobarbital (Luminal)FDA Link 08/2018 - 01/2006
4	oxidized low density lipoproteinIBA 04/2011 - 07/2003
3	CreatinineIBA 01/2021 - 06/2002
3	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2020 - 02/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 11/2005
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2017 - 02/2004
3	Mineralocorticoid Receptor AntagonistsIBA 04/2016 - 01/2014
3	Estrogens (Estrogen)FDA Link 09/2009 - 09/2004
3	Hemoglobins (Hemoglobin)IBA 05/2009 - 05/2003
3	LDL Lipoproteins (beta Lipoproteins)IBA 03/2009 - 01/2003
3	HDL CholesterolIBA 03/2009 - 02/2004
3	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 05/2007 - 02/2006
3	LipidsIBA 04/2005 - 06/2002
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2005 - 12/2002
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 04/2016
2	Thyroid HormonesIBA 05/2019 - 01/2019
2	Spironolactone (Aldactone)FDA LinkGeneric 04/2016 - 02/2016
2	Dihydrotachysterol (AT 10)IBA 09/2011 - 09/2011
2	Triglycerides (Triacylglycerol)IBA 03/2009 - 06/2006
2	Phytoestrogens (Phytoestrogen)IBA 05/2007 - 06/2006
2	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2007 - 02/2004
2	GenisteinIBA 05/2007 - 06/2006
2	LDL CholesterolIBA 06/2006 - 05/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2005 - 07/2005
2	AntioxidantsIBA 04/2005 - 05/2004
2	VitaminsIBA 04/2005 - 05/2004
2	Atorvastatin (Lipitor)FDA Link 04/2005 - 05/2004
1	Biological ProductsIBA 10/2021
1	AlbuminsIBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2020
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2020
1	Anti-Arrhythmia AgentsIBA 01/2020
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2020
1	Tranexamic Acid (AMCA)FDA Link 01/2020
1	Dobutamine FDA LinkGeneric 01/2019
1	Androstenedione (4 Androstene 3,17 dione)IBA 01/2016
1	Testosterone (Sustanon)FDA Link 01/2016
1	Angiotensin IIIBA 06/2014
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2014
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 06/2014
1	AldosteroneIBA 06/2014
1	SmokeIBA 03/2012
1	ORALIT (ORS)IBA 02/2012
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2011
1	salicylhydroxamic acid (SHAM)IBA 09/2011

Therapy/Procedure

29	Therapeutics 03/2022 - 05/2002
15	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 12/2007
13	Resuscitation 01/2021 - 04/2010
6	Cardiopulmonary Resuscitation (CPR) 12/2015 - 04/2010
6	Percutaneous Coronary Intervention 03/2012 - 06/2002
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2019 - 06/2010
2	Length of Stay 06/2010 - 11/2007
2	Catheters 11/2008 - 10/2005
1	Patient Readmission 01/2022
1	Drug Administration Routes 01/2020
1	Induced Hypothermia 11/2018
1	Defibrillators (Defibrillator) 01/2018